Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Trading Update

7 Nov 2017 07:00

RNS Number : 7184V
Ideagen PLC
07 November 2017
 

This announcement contains inside information.

  

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Trading Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, today provides an update on trading for the six months ended 31 October 2017.

The Board is pleased to report that trading has remained strong in the first half of the financial year and expects to report revenue and adjusted EBITDA* significantly ahead of the same period last year with an underlying organic revenue growth of approximately 12%. The Company continues to trade in line with market expectations for the full year to 30 April 2018.

Cash generation in the period was strong and the Company maintains a robust balance sheet with no debt. The cash balance at the period end was £5.9 million (30 April 2017: £4.8 million). 

David Hornsby, Chief Executive Officer of Ideagen, commented: "I am pleased to report yet another strong start to Ideagen's financial year. Our core markets are strong and underpin the demand we have seen this half. Cash generation has been excellent and the Group has seen further growth in its recurring revenues and repeat business.

The market opportunity remains large and long term and given the Group's position as a leader in the Governance, Risk and Compliance market, the Board is optimistic about the Group's continued growth prospects."

 *Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and other exceptional items.

 

 Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

 About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKQLFBDFFBFBD
Date   Source Headline
12th Nov 20207:00 amRNSPre-Close Trading Update and Board Changes
5th Nov 202010:46 amRNSPDMR Shareholding and Exercise of Options
4th Nov 20202:30 pmRNSHolding(s) in Company
29th Oct 202011:28 amRNSHolding(s) in Company
28th Oct 20203:59 pmRNSResult of AGM
21st Oct 20202:59 pmRNSHolding(s) in Company
16th Oct 202012:44 pmRNSExercise of share options and Total Voting Rights
14th Oct 20207:00 amRNSIssue of Equity and Total Voting Rights
5th Oct 20202:19 pmRNSNotice of AGM
2nd Oct 20201:52 pmRNSHolding(s) in Company
1st Oct 20208:28 amRNSPDMR Dealing and Exercise of Options
29th Sep 20205:51 pmRNSIssue of New Shares
22nd Sep 20207:00 amRNSFinal Results
15th Sep 20203:10 pmRNSHolding(s) in Company
24th Aug 20202:36 pmRNSHolding(s) in Company
19th Aug 20203:55 pmRNSIssue of New Shares
10th Aug 20207:00 amRNSTrading Update and Acquisition of Qualsys Ltd
14th Jul 20208:44 amRNSExercise of Options and TVR
1st Jul 20207:00 amRNSBoard Changes
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSExercise of Options and Total Voting Rights
16th Jun 20207:00 amRNSExercise of Options and TVR
26th May 20208:30 amRNSExercise of Options and TVR
22nd May 20207:00 amRNSPartnership with the World Health Organisation
21st May 20201:06 pmRNSHolding(s) in Company
19th May 20207:00 amRNSPre-Close Trading Update
28th Apr 20202:26 pmRNSExercise of Options and TVR
22nd Apr 20207:00 amRNSIssue of New Shares, Director Dealings and TVR
9th Apr 20207:00 amRNSExercise of Options and TVR
7th Apr 20207:00 amRNSCOVID-19 Trading Update
30th Mar 20207:00 amRNSIssue of new shares under SIP and TVR
6th Mar 20207:00 amRNSAcquisition of Workrite Ltd
25th Feb 202011:09 amRNSIssue of Equity
27th Jan 20204:56 pmRNSExercise of Options and TVR
22nd Jan 20207:00 amRNSInterim Results
20th Jan 20205:10 pmRNSIssue of Equity under Share Incentive Plan
7th Jan 20207:00 amRNSBoard Change
17th Dec 20194:08 pmRNSIssue of Equity
13th Dec 20194:38 pmRNSDirector/PDMR Shareholding
3rd Dec 20192:44 pmRNSHolding(s) in Company
2nd Dec 201911:29 amRNSPDMR Dealing and Total Voting Rights
29th Nov 20199:57 amRNSHolding(s) in Company
21st Nov 20194:06 pmRNSHolding(s) in Company
20th Nov 201911:58 amRNSDirector/PDMR Dealings and Total Voting Rights
18th Nov 20192:00 pmRNSIssue of Shares under Share Incentive Plan
13th Nov 20197:00 amRNSTrading Update
30th Oct 20193:48 pmRNSResult of AGM
24th Oct 20197:00 amRNSBoard Change
23rd Oct 201911:45 amRNSShare Incentive Plan and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.